The endocannabinoid system (ECS) is a composite cell-signaling system that allows endogenous cannabinoid ligands to control cell functions through the interaction with cannabinoid receptors. Modifications of the ECS might contribute to the pathogenesis of different diseases, including cancers. However, the use of these compounds as antitumor agents remains debatable.
The post Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies appeared first on Society of Cannabis Clinicians.